Current Treatment Recommendations for Topical Burn Therapy
- 42 Downloads
Infections in burn patients continue to be the primary source of morbidity and mortality. Topical antimicrobial therapy remains the single most important component of wound care in hospitalised burn patients. The goal of prophylactic topical antimicrobial therapy is to control microbial colonisation and prevent burn wound infection. In selected clinical circumstances topical agents may be used to treat incipient or early burn wound infections. At the present time silver sulfadiazine is the most frequently used topical prophylactic agent; it is relatively inexpensive, easy to apply, well tolerated by patients, and has good activity against most burn pathogens. In patients with large burns the addition of cerium nitrate to silver sulfadiazine may improve bacterial control. Mafenide acetate has superior eschar-penetrating characteristics, making it the agent of choice for early treatment of burn wound sepsis. However, the duration and area of mafenide application must be limited because of systemic toxicity associated with prolonged or extensive use. Other agents, such as nitrofurazone or chlorhexidine preparations, may be useful in isolated clinical situations. The undesirable side effects of silver nitrate solution limit its use by most clinicians at the present time.
KeywordsCerium Silver Nitrate Sulfadiazine Topical Agent Cerium Nitrate
Unable to display preview. Download preview PDF.
- Curreri WP. Burns. In Howard RJ & Simmons RL (Eds) Surgical infectious disease, pp. 873–881, Appleton Lange, Norwalk, 1988Google Scholar
- Noble WC, Sommerville DA (Eds). Microbiology of human skin, Saunders, Philadelphia, 1974Google Scholar
- Order SE, Moncrief JA. The burn wound, pp. 36–45, Charles C. Thomas, Springfield, Illinois, 1965Google Scholar
- Pruitt BA, Goodwin CW. Thermal injuries. In Davis JH (Ed.) Clinical surgery, pp. 2823–2904, Mosby, St Louis, 1987Google Scholar
- Pruitt BA, Lindbergh RB. Pseudomonas aeruginosa infections in burned patients. In Dogget RG (Ed.) Pseudomonas aeruginosa, pp. 339–366, Academic Press Inc., New York, 1979Google Scholar
- Simmons RL, Ahrenholz DH. Infections of the skin and soft tissue. In Howard RJ & Simmons RL (Eds) Surgical infectious disease, pp. 337–441, Appleton Lange, Norwalk, 1988Google Scholar
- Smith-Choban P, Marshall WJ. Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences. American Surgeon 53: 515–517, 1987Google Scholar